NCT02194010

Brief Summary

The purpose of this research study is to create and validate two patient reported outcome (PRO) questionnaires. PRO questionnaires ask questions that help to measure disability in patients with inherited neuropathies. These questionnaires ask questions about what participants think disability is for themselves or others with inherited neuropathies. These questionnaires are a useful tool when evaluating whether treatments are working in the day to day life of an individual, although there are currently no questionnaires available specifically for people who have Charcot Marie Tooth disease (CMT).

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
563

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2014

Longer than P75 for all trials

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 2, 2014

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 18, 2014

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2019

Completed
Last Updated

February 7, 2019

Status Verified

February 1, 2019

Enrollment Period

4.8 years

First QC Date

April 2, 2014

Last Update Submit

February 6, 2019

Conditions

Keywords

Outcome MeasurePatient Reported Questionnaires

Outcome Measures

Primary Outcomes (1)

  • Disability Severity Index

    The DSI asks the subject to provide information about how disability is reflected in general by equipment required for mobility. Therefore, the DSI asks the subject if a person in general was wearing AFOs (braces) for mobility, what level of disability would that reflect using both a quantitative measurement of score and a verbal method of scoring (none, mild, moderate, severe). These questions do not apply to the participant themselves, just in general how disabled they believe a person to be based on the mobility assistive devices that that person requires. Then a research team member will complete the last page which specifically asks about what that subject is using for mobility.

    Approximately 30 minutes

Secondary Outcomes (1)

  • Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)

    Approximately 30 minutes

Study Arms (2)

Participants evaluated at INC sites

Participants being evaluated at the INC sites will participate in both the DSI and HMSN-R-ODS by completing these PROs during their visit.

INC Contact Registry

INC Contact Registry completes the HMSN-R-ODS on web http://rarediseasesnetwork.epi.usf.edu/INC/

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants enrolled in INC protocol 6601 and being seen at a participating site for an evaluation of CMT will be asked if they would like to participate in this protocol. The individuals being recruited will have already signed consent forms and be enrolled in 6601. They will be informed that it is completely voluntary to participate in this protocol, and they can still be enrolled in INC 6601 without participating in this project. Alternative participants who are registered with our INC Patient Registry will be alerted to the form through an email and asked to participate due to their diagnosis of suspected diagnosis of CMT.

You may qualify if:

  • individual has an inherited peripheral neuropathy or is suspected to have an inherited peripheral neuropathy
  • individual is 10-99 years of age
  • individual signs consent or assent form depending on age and requirements
  • individual is participating in INC 6601 at one of the participating sites OR is a participant on the INC Patient Registry

You may not qualify if:

  • inability to provide informed consent
  • outside of age range
  • inability to complete questionnaire
  • does not understand English
  • is not participating in INC 6601 or on the INC Patient Registry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Iowa

Iowa City, Iowa, 52242, United States

Location

University of Rochester Medical Center

Rochester, New York, 14627, United States

Location

National Hospital of Neurology and Neurosurgery

London, United Kingdom

Location

MeSH Terms

Conditions

Charcot-Marie-Tooth DiseaseInherited Peripheral Neuropathy

Condition Hierarchy (Ancestors)

Hereditary Sensory and Motor NeuropathyNervous System MalformationsNervous System DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesPolyneuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, Inborn

Study Officials

  • Michael E Shy, MD

    Universit of Iowa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Neurology

Study Record Dates

First Submitted

April 2, 2014

First Posted

July 18, 2014

Study Start

April 1, 2014

Primary Completion

February 1, 2019

Study Completion

February 1, 2019

Last Updated

February 7, 2019

Record last verified: 2019-02

Locations